These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3354019

  • 1. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F.
    Hall ED, Yonkers PA.
    Stroke; 1988 Mar; 19(3):340-4. PubMed ID: 3354019
    [Abstract] [Full Text] [Related]

  • 2. Effects of the nonglucocorticoid 21-aminosteroid U74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage.
    Hall ED, Travis MA.
    Exp Neurol; 1988 Nov; 102(2):244-8. PubMed ID: 3181364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
    Hall ED, Yonkers PA, Horan KL, Braughler JM.
    J Neurotrauma; 1989 Nov; 6(3):169-76. PubMed ID: 2810381
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs.
    Perkins WJ, Milde LN, Milde JH, Michenfelder JD.
    Stroke; 1991 Jul; 22(7):902-9. PubMed ID: 1853410
    [Abstract] [Full Text] [Related]

  • 11. Delayed adjuvant therapy with the 21-aminosteroid U74006F and the anion channel blocker L644-711 does not improve outcome following thrombolytic therapy in a rabbit model of thromboembolic stroke.
    Gross CE, Kimelberg HK, Raymond-Russell S, Booth C, Bednar MM.
    Surg Neurol; 1997 Jan; 47(1):60-5; discussion 66-7. PubMed ID: 8986168
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F.
    Stanley JJ, Goldblum JR, Frank TS, Zelenock GB, D'Alecy LG.
    J Vasc Surg; 1993 Apr; 17(4):685-9. PubMed ID: 8464086
    [Abstract] [Full Text] [Related]

  • 13. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
    Umemura K, Wada K, Uematsu T, Mizuno A, Nakashima M.
    Eur J Pharmacol; 1994 Jan 04; 251(1):69-74. PubMed ID: 8137871
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F.
    Hall ED, Yonkers PA, McCall JM.
    Eur J Pharmacol; 1988 Mar 01; 147(2):299-303. PubMed ID: 3366180
    [Abstract] [Full Text] [Related]

  • 15. The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke.
    Wilson JT, Bednar MM, McAuliffe TL, Raymond S, Gross CE.
    Neurosurgery; 1992 Nov 01; 31(5):929-33; discussion 933-4. PubMed ID: 1436419
    [Abstract] [Full Text] [Related]

  • 16. Tirilazad mesylate does not improve early cerebral metabolic recovery following compression ischemia in dogs.
    Helfaer MA, Kirsch JR, Hurn PD, Blizzard KK, Koehler RC, Traystman RJ.
    Stroke; 1992 Oct 01; 23(10):1479-85; discussion 1485-6. PubMed ID: 1412585
    [Abstract] [Full Text] [Related]

  • 17. The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat.
    McIntosh TK, Thomas M, Smith D, Banbury M.
    J Neurotrauma; 1992 Oct 01; 9(1):33-46. PubMed ID: 1619674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.